VeriMom¿Es monascus extract seguro durante el embarazo?
Monascus extracts commonly contain monacolin K, which EFSA and other assessments treat as identical to lovastatin; statins have documented developmental/embryofetal concerns in animal studies and are clinically contraindicated or advised against in pregnancy—this supports a suspected reproductive hazard (h=2). The mechanism (HMG‑CoA reductase inhibition altering cholesterol biosynthesis needed for fetal development) is demonstrated (m=2). Topical cosmetic exposure is likely low but measurable (e=1). Sources: EFSA/scientific opinion on monacolins, FDA/statin pregnancy communications, and statin pregnancy reviews.
Alternativas seguras a monascus extract en el embarazo | VeriMom
Related ingredients
Frequently asked questions
- ¿Es monascus extract seguro durante el embarazo?
- Monascus extracts commonly contain monacolin K, which EFSA and other assessments treat as identical to lovastatin; statins have documented developmental/embryofetal concerns in animal studies and are clinically contraindicated or advised against in pregnancy—this supports a suspected reproductive hazard (h=2). The mechanism (HMG‑CoA reductase inhibition altering cholesterol biosynthesis needed for fetal development) is demonstrated (m=2). Topical cosmetic exposure is likely low but measurable (e=1). Sources: EFSA/scientific opinion on monacolins, FDA/statin pregnancy communications, and statin pregnancy reviews.
- ¿Es monascus extract seguro durante la lactancia?
- Because monacolin K = lovastatin and statins have been advised against in breastfeeding (potential for infant exposure and drug effects), the same suspected hazard (h=2) and demonstrated mechanism (m=2) apply. Topical absorption from cosmetics is expected to be low but measurable (e=1). Clinical/regulatory guidance recommends avoiding statins in breastfeeding. Sources: FDA statements and clinical reviews.
- ¿Es monascus extract seguro para la piel del bebé?
- Do not increase hazard or mechanism absent infant‑specific toxicology, but exposure (e) is increased by +1 for infants due to immature skin barrier/higher surface‑area‑to‑weight. Thus e=2 when an extract contains absorbable monacolin K. Additionally, contamination risk with citrinin (a nephrotoxic mycotoxin) in some Monascus products is relevant for infant safety.
- ¿Cómo puntúa VeriMom a monascus extract?
- VeriMom puntúa monascus extract en 40/100 (riesgo medio) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a monascus extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a monascus extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.